• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS TORIC II 1-PIECE ACRYLIC; TORIC IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS TORIC II 1-PIECE ACRYLIC; TORIC IOLS Back to Search Results
Model Number ZCU150
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); No Code Available (3191)
Date of Event 05/11/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If explanted; give date: n/a (not applicable).The lens remains implanted.(b)(4).Device evaluation: the device was not returned at the manufacturing site; it remains implanted therefore; product testing could not be performed, and the customer¿s reported complaint could not be verified.Manufacturing record review: the manufacturing records for the intraocular lens were reviewed.The product was manufactured according to specifications.The search revealed that no other complaint for this production order number has been received.Conclusion: as a result of the investigation there is no indication of a product quality deficiency.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that an intraocular lens (iol) was repositioned due to a refractive surprise in the patient's left eye.Through follow-up, it was learned that the patient experienced blurred vision and there was a loss of 2 or more lines best spectacle-corrected visual acuity (bscva).The original planned axis of the lens appeared to have been incorrect, therefore, the lens was repositioned.The patient is doing well and the lens is in the new location.The patient is still unhappy with his current uncorrected vision.The lens remains implanted at this time.No other information was provided.
 
Additional Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are nr-0148919 and capa-010215.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS TORIC II 1-PIECE ACRYLIC
Common Device Name
TORIC IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key10141346
Report Number9614546-2020-00220
Device Sequence Number14093491
Product Code HQL
UDI-Device Identifier05050474657847
UDI-Public(01)05050474657847(17)240916
Combination Product (Y/N)Y
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/30/2020
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/16/2024
Device Model NumberZCU150
Device Catalogue NumberZCU150U225
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 05/18/2020
Supplement Date Received by Manufacturer10/25/2020
Initial Report FDA Received Date06/10/2020
Supplement Report FDA Received Date10/30/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Date Report Sent to FDA01/01/2005
-
-